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ABSTRACT 
Unaccustomed strenuous exercise can lead to muscle strength loss, inflammation and delayed 
onset muscle soreness, which may be influenced by genetic variation. We investigated if a 
missense single nucleotide polymorphism (A>G, rs2275950) within the TRIM63 gene (encoding 
MuRF-1 and potentially affecting titin mechanical properties) was associated with the variable 
response to unaccustomed eccentric exercise. Sixty-five untrained, healthy participants 
(genotyped for rs2275950: AA, AG and GG) performed 120 maximal eccentric knee extensions 
(ECC) to induce muscle damage. Isometric and isokinetic maximal voluntary knee extension 
contractions (MVCs) and muscle soreness were assessed before, immediately after, and 48h 
after ECC. AA homozygotes were consistently stronger [baseline isometric MVC: 3.23±0.92 
Nm/kg (AA) vs. 2.09±0.67 Nm/kg (GG); p=0.006] and demonstrated less muscle soreness over 
time (p=0.022) compared to GG homozygotes. This may be explained by greater titin stiffness 
in AA homozygotes, leading to intrinsically stronger muscle fibers that are more resistant to 
eccentric damaging contractions.  
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BACKGROUND/MOTIVATION FOR THE STUDY
Unaccustomed strenuous exercise can lead to muscle strength loss, inflammation and delayed 
onset muscle soreness, which are biomarkers of exercise-induced muscle damage (EIMD) (3). 
Insufficient recovery from EIMD may increase injury risk, and there is evidence that people 
recover at different rates (3), which may be influenced by genetic variation (1).  
Muscle RING finger-1 (MuRF-1) is known to be associated with cardiomyopathy and muscle 
atrophy (6) and it plays a crucial role in the ubiquitin proteasome system by attaching ubiquitin 
polymers to damaged myofibrillar proteins following EIMD, thus enabling the 26S-proteasome 
complex to degrade these ubiquitin-marked proteins (4). MuRF-1 is localized at the Z- and also 
the M-line of the sarcomere, where it also interacts with the strain sensing kinase domain of the 
sarcomeric protein, titin (2). This kinase domain is thought to modulate the mechanical 
properties of titin and the gene expression of other muscle-encoding proteins (5).  
MuRF-1 is encoded by the human tripartite motif containing 63 (TRIM63) gene, in which a 
missense single nucleotide polymorphism (SNP, A>G, rs2275950) at amino acid 237 causes a 
change from lysine to glutamate. This may decrease MuRF-1’s affinity for the titin strain sensing 
kinase domain, thus reducing muscle fiber stiffness and increasing its susceptibility to EIMD. To 
our knowledge, however, this SNP has not yet been linked to any phenotypic trait. We therefore 
aimed to investigate an association between this SNP and EIMD in untrained young men and 
women. We hypothesized that (i) the minor G-allele would be associated with lower muscle 
strength, and (ii) G-allele carriers would exhibit a greater damage response following maximal 
eccentric exercise compared to AA homozygotes. 
 
 
PHENOTYPE
To induce quadriceps femoris muscle damage, familiarized participants performed 12 sets of 10 
maximal eccentric unilateral contractions of the knee extensors. Maximum isometric (at 80º 
knee flexion) and isokinetic (60º/s) voluntary knee-extension contraction (MVC) torque (Humac 
Norm, CSI Inc, Stoughton, MA, and Biodex Multi-Joint System 3 Pro Inc, Shirley, NY) 
normalized to body mass, muscle soreness (measured by visual analogue scale in conjunction 
with a three repetition bodyweight squat) were assessed before, immediately after and 48 h 
after the EIMD intervention. Venous blood samples were collected from an antecubital vein for 
genotypic (1x10 ml; BD EDTA vacutainer) and serum analysis (3x10 ml; BD serum collection 
vacutainer). Serum tubes were centrifuged at 1,300 g for 15 min (4°C) and all samples were 
stored at −80°C. Serum creatine kinase (CK) activity (Catachem Inc., Connecticut, NE) was 
analyzed according to manufacturer protocols. 
 
 
Cohort details
Following ethical approval from Liverpool John Moores University Ethics Committee, and in 
accordance with the Declaration of Helsinki, written informed consent was obtained from our 
population cohort, which comprised young, untrained, healthy (identified by physical activity and 
health questionnaires) female (n=39) and male (n=26) Caucasians (mean ± SD: 
age = 22.5 ± 4.0 year; height = 1.71 ± 0.09 m; body mass = 70.9 ± 14.4 kg). Inclusion criteria 
were: aged between 18-35 years and no history of (i) leg strength training in the past 6 months, 
(ii) muscle-tendon injury in the last 12 months, and (iii) bone fracture in the lower limbs. 
Participants were requested to maintain their normal daily routine and to refrain from consuming 
alcohol or participating in any exercise for two days prior to the study and throughout the 
intervention.  
 
 
Type of study
For this candidate SNP study, extraction of the DNA was carried out using QIAamp DNA Blood 
Kit (Qiagen, Crawley, UK) and following the spin protocol for DNA purification from whole blood. 
Real-time polymerase chain reaction (PCR) was performed with Rotor-Gene Q (Qiagen) to 
determine TRIM63 (A>G, rs2275950) genotype in each participant. Reactions were completed 
on a 72-well rotor-disc. Each 10 µL reaction volume contained: 5 µL Genotyping Master Mix, 0.5 
µL genotyping assay mix (Applied Biosystems,  Foster City, CA), 3.5 µL nuclease-free H2O 
(Qiagen) and 1 µL DNA. For control wells, 1 µL nuclease-free H2O replaced the DNA template. 
The following PCR protocol was used: 40 cycles of incubation at 92°C for 15s (denaturation), 
then annealing and extension at 60°C for 1min. Lastly, genotype was determined in all samples 
(analyzed in duplicate), using Rotor-Gene Q Software 2.3.1 (Qiagen).  
 
 
Details of the SNP(s) studied
The investigated SNP (rs2275950) is located in the Tripartite Motif Containing 63 gene 
(TRIM63), on chromosome 1 at position 26,058,512 (dbSNP Build 150). This missense A>G 
(adenine to guanine) SNP has not previously been associated with the response to exercise. 
The frequency of the effect (major) A allele is 0.77. Linkage disequilibrium (LD) calculations for 
the TRIM63 SNP were performed using the LDlink suite and data from the 1000 Genomes 
Project European ancestry populations (7, 8). 
 
 
Analysis model
Data for each parameter were assessed for normal distribution with the Shapiro-Wilk test and by 
inspection of the Q-Q plots. Hardy-Weinberg equilibrium was determined for the TRIM63 SNP 
using a x2 test. Two-way mixed ANCOVAs [within-subjects factor: time (pre, post- and 48h post; 
between-subjects factor: genotype (AA, AG, GG); covariate: sex] with Tukey post-hoc tests 
were used to detect associations between the TRIM63 SNP and isometric and isokinetic MVC 
knee-extension torque (normalized to body mass), muscle soreness, and serum CK activity over 
time. All data are presented as mean (± SD), and statistical significance was identified when P < 
0.05. All MVC data were recorded in AcqKnowledge software (Version 4.2, Biopac-Systems Inc., 
Goleta, USA) and statistical analysis was performed with SPSS (v23, IBM Inc., Armonk, NY). 
 
 
RESULTS
Genotype frequency distribution for the TRIM63 (rs2275950; X2=1.156, P=0.282) SNP was in 
Hardy-Weinberg equilibrium. Forty participants were AA, 20 AG, and five were GG genotype. 
Normalized isometric (p<0.001) and isokinetic (p<0.001) MVC, leg muscle soreness (p<0.001) 
and CK activity (p=0.01) all showed a main effect of time, indicating EIMD. There was a main 
effect for genotype regarding normalized isometric (p=0.006, Fig. 1) and isokinetic (p=0.031) 
MVC, with AA stronger than GG in both cases [isometric MVC normalized to body mass at pre-
EIMD: 3.23±0.92 Nm/kg (AA) vs. 2.67±1.09 Nm/kg (AG) vs. 2.09±0.67 Nm/kg (GG)]. There was 
a genotype x time interaction regarding muscle soreness (p=0.022), with AA homozygotes 
showing attenuated muscle soreness 48 h post-EIMD compared to AG and GG genotypes 
(2.9±2.2 cm vs. 4.5±2.3 cm and 5.4±2.2 cm, respectively; Fig. 2). 
 
 
INTERPRETATION
Homozygotes of the major TRIM63 A-allele were stronger (relative to body mass) and 
recovered quicker following strenuous exercise compared to G-allele carriers. It is possible that 
the A-allele is linked to a higher affinity for titin’s strain sensing kinase domain, leading to 
greater kinase activation. This may improve the mechanical properties of titin, enabling a stiffer 
muscle fiber to transmit more force laterally and longitudinally, potentially making the fiber 
intrinsically stronger and more resistant to acute damaging eccentric contractions. However, 
rs2275950 is in LD with other TRIM63 SNPs, and with SNPs within the exostosin-like 1 (EXTL1) 
and the solute carrier family 30 member 2 (SLC30A2) genes. Nevertheless, given MuRF-1’s 
role in muscle protein degradation and with titin’s strain sensing kinase domain, rs2275950 is a 
likely genetic determinant of the inter-individual variability in the human response to EIMD. 
Further work is necessary to elucidate if (i) other TRIM63, EXTL1 and/or SLC30A2 SNPs (either 
in combination or isolation) are of functional significance regarding EIMD; (ii) this quicker 
recovery following an acute bout of intense exercise in AA homozygotes compared to G-allele 
carriers translates into greater muscle hypertrophy and/or strength gains following chronic 
resistance training.  
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Appendix 1 Figure 1 
 
Figure 1. Isometric knee extension maximal voluntary contraction torque normalized to body mass for individuals of 
the three TRIM63 (A>G, rs2275950) genotypes before (Pre), directly after (Post) and 48h after (48 h Post) a 
strenuous exercise intervention. * indicates significant differences (p< 0.05) between the AA and GG genotypes. 
MVC = Maximal voluntary contraction. Values are mean ± SD. 
 
 
  
Appendix 1 Figure 2 
 
Figure 2. Muscle Soreness measured via Visual Analogue Scale for individuals of the three TRIM63 (A>G, 
rs2275950) genotypes assessed before (Pre), directly after (Post) and 48h after (48 h Post) 120 a strenuous exercise 
intervention. * indicates significant differences (p< 0.05) between AA and GG genotypes. † indicates significant 
differences (p< 0.05) between AA and AG genotypes. Values are mean ± SD. 
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